Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €34.19 EUR
Change Today +0.403 / 1.19%
Volume 0.0
ADY On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 3:40 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

amedisys inc (ADY) Snapshot

Open
€34.02
Previous Close
€33.79
Day High
€34.95
Day Low
€33.63
52 Week High
08/5/15 - €44.13
52 Week Low
10/15/14 - €15.32
Market Cap
1.2B
Average Volume 10 Days
150.0
EPS TTM
--
Shares Outstanding
33.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMEDISYS INC (ADY)

amedisys inc (ADY) Related Businessweek News

View More BusinessWeek News

amedisys inc (ADY) Details

Amedisys Inc. provides home health and hospice services including practical nursing services and physical and occupational therapy. The company’s services also comprise speech pathology, social work to help families address acute and chronic illnesses, home health aide services, and private duty services. Hospice services use a team made up of a physician, patient care manager, registered nurses, certified home health aides, social workers, a chaplain, a homemaker, and volunteers. As of Apr. 4, 2007, the company operated 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states. Amedisys was founded in 1982 and is headquartered in Baton Rouge, La.

13,200 Employees
Last Reported Date: 03/4/15
Founded in 1982

amedisys inc (ADY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Vice Chairman and Chief Financial Officer
Total Annual Compensation: $597.3K
Chief Compliance Officer and Corporate Counse...
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2014.

amedisys inc (ADY) Key Developments

Amedisys Mulls Acquisitions

Amedisys Inc. (NasdaqGS:AMED) is seeking acquisitions. Paul Kusserow, Chief Executive Officer of Amedisys, said, “The company is looking at more than 200 candidates for acquisitions, joint ventures and other partnerships. Amedisys has compiled a long list of potential acquisition targets as it prepares for a shakeout in the highly fragmented home healthcare industry. The company is looking at deals in the range of $50 million and higher, as well as smaller tuck-in acquisitions, on both the home healthcare and hospice sides of its business.

Amedisys Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Amedisys Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported operating income of $15,527,000, income before tax of $18,439,000, income from continuing operations of $10,873,000 and income from continuing operations attributable to shareholders of $10,637,000 or $0.32 per diluted share against operating income of $12,561,000, income before tax of $12,353,000, income from continuing operations of $7,610,000 and income from continuing operations attributable to shareholders of $7,558,000 or $0.23 per diluted share reported for the same period a year ago. The company reported net income of $10,873,000 and net income attributable to the company of $10,637,000 or $0.32 per diluted share on net service revenue of $314,152,000 against net income of $7,671,000 and net income attributable to the company of $7,619,000 or $0.23 per diluted share on net service revenue of $305,006,000 reported a year ago. Net cash provided by operating activities was $42,554,000 against net cash used in operating activities of $89,129,000 a year ago. EBITDA was $25,230,000 against $21,329,000 a year ago. Adjusted EBITDA was $31,657,000 against $22,113,000 a year ago. Adjusted net income from continuing operations attributable to the company was $14,525,000 or $0.43 per diluted share against $8,040,000 or $0.25 per diluted share a year ago. For the six months period, the company reported operating loss of $42,577,000, loss before tax of $37,984,000, loss from continuing operations of $23,959,000 and loss from continuing operations attributable to shareholders of $24,372,000 or $0.74 per diluted share against operating loss of $7,012,000, loss before tax of $7,498,000, loss from continuing operations of $4,623,000 and loss from continuing operations attributable to shareholders of $4,582,000 or $0.14 per diluted share reported for the same period a year ago. The company reported net loss of $23,959,000 and net loss attributable to the company of $24,372,000 or $0.74 per diluted share on net service revenue of $615,724,000 against net loss of $4,798,000 and net loss attributable to the company of $4,798,000 or $0.15 per diluted share on net service revenue of $603,745,000 reported a year ago. Net cash provided by operating activities was $57,037,000 against net cash used in operating activities of $95,471,000 a year ago. LBITDA was $22,429,000 against EBITDA of $10,728,000 a year ago. Adjusted EBITDA was $58,038,000 against $27,612,000 a year ago. Adjusted net income from continuing operations attributable to the company was $24,310,000 or $0.73 per diluted share against $5,818,000 or $0.18 per diluted share a year ago.

Amedisys Mulls Acquisitions

Amedisys Inc. (NasdaqGS:AMED) intends to pursue acquisitions. "In addition to driving organic growth, we are continuing to pursue M&A opportunities," Paul Kusserow, President and Chief Executive Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADY:GR €34.19 EUR +0.403

ADY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Capital Senior Living Corp $21.13 USD -0.04
Chemed Corp $138.53 USD -0.85
LHC Group Inc $43.46 USD -0.22
National HealthCare Corp $60.93 USD -0.28
Ensign Group Inc/The $47.21 USD +0.23
View Industry Companies
 

Industry Analysis

ADY

Industry Average

Valuation ADY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 3.5x
Price/Cash Flow 77.1x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMEDISYS INC, please visit www.amedisys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.